LYNX PHARMA AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−573k kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−51k kr).

LYNX PHARMA AS is registered as a limited company in Færder, Vestfold with organisation number 931174673. The business is classified under other health services (NACE 86.993). The company was incorporated in 2023. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Selge tjenester og varer innen legetjenester, helse, skjønnhet og velvære og annet som naturlig sammenfaller med dette, samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.”.

Key figures · 2024

Operating profit

NOK −51,000

Equity

NOK −573,000

Financial health · 2024

Liquidity

0.29

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-242.2%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns LYNX PHARMA AS?

YTRE HATTHOLMEN AS

100.0%

LYNX PHARMA AS

· NOK −51,000 profit

LYNX PHARMA AS has 1 registered shareholder:

• YTRE HATTHOLMEN AS 100.0%

All shareholders and roles →

Frequently asked questions about LYNX PHARMA AS

Who owns LYNX PHARMA AS?

YTRE HATTHOLMEN AS is the largest registered owner, with 100.0%.

Where is LYNX PHARMA AS based?

LYNX PHARMA AS has its business address in Torød.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.